Modern treatment modalities for neonatal and pediatric respiratory failure

Robert M. Arensman, Mindy B. Statter, Amir L. Bastawrous, Mary Beth Madonna

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

BACKGROUND: Respiratory failure secondary to a variety of causes remains a significant cause of morbidity and mortality in the pediatric population. Newer therapies are appearing frequently in an attempt to decrease the number of deaths from this disease state. We briefly review the current literature on some of the newer modalities including: high-frequency ventilation, surfactant, liquid ventilation, and nitric oxide. We then present our experience from the past 11 years in the most invasive, yet successful, therapy for acute respiratory failure-extracorporeal membrane oxygenation (ECMO). METHODS: Retrospective review of all patients treated with ECMO from September 1983 to December 1994 was undertaken. Data were collected from bedside ECMO flow sheets and the standardized data entry forms submitted to the Extracorporeal Life Support Organization. All statistical analyses were performed using a standard statistical software program. RESULTS: During the study period, 194 neonates and 47 pediatric patients were treated with ECMO. The survival rate in the neonatal population is 82% and in the pediatric population it is 40%. The neonatal patients required an average of 153 hours of support while the pediatric patients required 220 hours (P = 0.008). CONCLUSIONS: While the newer treatment modalities discussed may have an important role in treating neonatal and pediatric respiratory failure in the near future, ECMO remains a cornerstone of the modern treatment modalities. Although somewhat invasive, ECMO is effective therapy with increasing survival rates each year.

Original languageEnglish (US)
Pages (from-to)41-47
Number of pages7
JournalAmerican Journal of Surgery
Volume172
Issue number1
DOIs
StatePublished - Jul 1996
Externally publishedYes

Fingerprint

Extracorporeal Membrane Oxygenation
Respiratory Insufficiency
Pediatrics
Therapeutics
Survival Rate
Liquid Ventilation
Population
High-Frequency Ventilation
Surface-Active Agents
Nitric Oxide
Software
Organizations
Newborn Infant
Morbidity
Mortality

ASJC Scopus subject areas

  • Surgery

Cite this

Modern treatment modalities for neonatal and pediatric respiratory failure. / Arensman, Robert M.; Statter, Mindy B.; Bastawrous, Amir L.; Madonna, Mary Beth.

In: American Journal of Surgery, Vol. 172, No. 1, 07.1996, p. 41-47.

Research output: Contribution to journalArticle

Arensman, Robert M. ; Statter, Mindy B. ; Bastawrous, Amir L. ; Madonna, Mary Beth. / Modern treatment modalities for neonatal and pediatric respiratory failure. In: American Journal of Surgery. 1996 ; Vol. 172, No. 1. pp. 41-47.
@article{9f29913d26b543969f0ddb79d29ae7b8,
title = "Modern treatment modalities for neonatal and pediatric respiratory failure",
abstract = "BACKGROUND: Respiratory failure secondary to a variety of causes remains a significant cause of morbidity and mortality in the pediatric population. Newer therapies are appearing frequently in an attempt to decrease the number of deaths from this disease state. We briefly review the current literature on some of the newer modalities including: high-frequency ventilation, surfactant, liquid ventilation, and nitric oxide. We then present our experience from the past 11 years in the most invasive, yet successful, therapy for acute respiratory failure-extracorporeal membrane oxygenation (ECMO). METHODS: Retrospective review of all patients treated with ECMO from September 1983 to December 1994 was undertaken. Data were collected from bedside ECMO flow sheets and the standardized data entry forms submitted to the Extracorporeal Life Support Organization. All statistical analyses were performed using a standard statistical software program. RESULTS: During the study period, 194 neonates and 47 pediatric patients were treated with ECMO. The survival rate in the neonatal population is 82{\%} and in the pediatric population it is 40{\%}. The neonatal patients required an average of 153 hours of support while the pediatric patients required 220 hours (P = 0.008). CONCLUSIONS: While the newer treatment modalities discussed may have an important role in treating neonatal and pediatric respiratory failure in the near future, ECMO remains a cornerstone of the modern treatment modalities. Although somewhat invasive, ECMO is effective therapy with increasing survival rates each year.",
author = "Arensman, {Robert M.} and Statter, {Mindy B.} and Bastawrous, {Amir L.} and Madonna, {Mary Beth}",
year = "1996",
month = "7",
doi = "10.1016/S0002-9610(96)00057-8",
language = "English (US)",
volume = "172",
pages = "41--47",
journal = "American Journal of Surgery",
issn = "0002-9610",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Modern treatment modalities for neonatal and pediatric respiratory failure

AU - Arensman, Robert M.

AU - Statter, Mindy B.

AU - Bastawrous, Amir L.

AU - Madonna, Mary Beth

PY - 1996/7

Y1 - 1996/7

N2 - BACKGROUND: Respiratory failure secondary to a variety of causes remains a significant cause of morbidity and mortality in the pediatric population. Newer therapies are appearing frequently in an attempt to decrease the number of deaths from this disease state. We briefly review the current literature on some of the newer modalities including: high-frequency ventilation, surfactant, liquid ventilation, and nitric oxide. We then present our experience from the past 11 years in the most invasive, yet successful, therapy for acute respiratory failure-extracorporeal membrane oxygenation (ECMO). METHODS: Retrospective review of all patients treated with ECMO from September 1983 to December 1994 was undertaken. Data were collected from bedside ECMO flow sheets and the standardized data entry forms submitted to the Extracorporeal Life Support Organization. All statistical analyses were performed using a standard statistical software program. RESULTS: During the study period, 194 neonates and 47 pediatric patients were treated with ECMO. The survival rate in the neonatal population is 82% and in the pediatric population it is 40%. The neonatal patients required an average of 153 hours of support while the pediatric patients required 220 hours (P = 0.008). CONCLUSIONS: While the newer treatment modalities discussed may have an important role in treating neonatal and pediatric respiratory failure in the near future, ECMO remains a cornerstone of the modern treatment modalities. Although somewhat invasive, ECMO is effective therapy with increasing survival rates each year.

AB - BACKGROUND: Respiratory failure secondary to a variety of causes remains a significant cause of morbidity and mortality in the pediatric population. Newer therapies are appearing frequently in an attempt to decrease the number of deaths from this disease state. We briefly review the current literature on some of the newer modalities including: high-frequency ventilation, surfactant, liquid ventilation, and nitric oxide. We then present our experience from the past 11 years in the most invasive, yet successful, therapy for acute respiratory failure-extracorporeal membrane oxygenation (ECMO). METHODS: Retrospective review of all patients treated with ECMO from September 1983 to December 1994 was undertaken. Data were collected from bedside ECMO flow sheets and the standardized data entry forms submitted to the Extracorporeal Life Support Organization. All statistical analyses were performed using a standard statistical software program. RESULTS: During the study period, 194 neonates and 47 pediatric patients were treated with ECMO. The survival rate in the neonatal population is 82% and in the pediatric population it is 40%. The neonatal patients required an average of 153 hours of support while the pediatric patients required 220 hours (P = 0.008). CONCLUSIONS: While the newer treatment modalities discussed may have an important role in treating neonatal and pediatric respiratory failure in the near future, ECMO remains a cornerstone of the modern treatment modalities. Although somewhat invasive, ECMO is effective therapy with increasing survival rates each year.

UR - http://www.scopus.com/inward/record.url?scp=0030198843&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030198843&partnerID=8YFLogxK

U2 - 10.1016/S0002-9610(96)00057-8

DO - 10.1016/S0002-9610(96)00057-8

M3 - Article

VL - 172

SP - 41

EP - 47

JO - American Journal of Surgery

JF - American Journal of Surgery

SN - 0002-9610

IS - 1

ER -